GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heartware International Inc (NAS:HTWR) » Definitions » PE Ratio (TTM)

Heartware International (Heartware International) PE Ratio (TTM) : At Loss (As of May. 11, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Heartware International PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-05-11), Heartware International's share price is $57.98. Heartware International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2016 was $-3.40. Therefore, Heartware International's PE Ratio (TTM) for today is At Loss.


The historical rank and industry rank for Heartware International's PE Ratio (TTM) or its related term are showing as below:

HTWR' s PE Ratio (TTM) Range Over the Past 10 Years
Min: At Loss   Med: At Loss   Max: At Loss
Current: At Loss



HTWR's PE Ratio (TTM) is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 30.055 vs HTWR: At Loss

Heartware International's Earnings per Share (Diluted) for the three months ended in Jun. 2016 was $-0.62. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2016 was $-3.40.

As of today (2024-05-11), Heartware International's share price is $57.98. Heartware International's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2016 was $-3.40. Therefore, Heartware International's PE Ratio without NRI for today is At Loss.

Heartware International's EPS without NRI for the three months ended in Jun. 2016 was $-0.62. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2016 was $-3.40.

Heartware International's EPS (Basic) for the three months ended in Jun. 2016 was $-0.62. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2016 was $-3.40.


Heartware International PE Ratio (TTM) Historical Data

The historical data trend for Heartware International's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heartware International PE Ratio (TTM) Chart

Heartware International Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Heartware International Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Heartware International's PE Ratio (TTM)

For the Medical Devices subindustry, Heartware International's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heartware International's PE Ratio (TTM) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Heartware International's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Heartware International's PE Ratio (TTM) falls into.



Heartware International PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Heartware International's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=57.98/-3.400
=At Loss

Heartware International's Share Price of today is $57.98.
Heartware International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.40.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Heartware International  (NAS:HTWR) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Heartware International PE Ratio (TTM) Related Terms

Thank you for viewing the detailed overview of Heartware International's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Heartware International (Heartware International) Business Description

Traded in Other Exchanges
N/A
Address
Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.
Executives
Larkin C Raymond Jr director C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105
Stephen N. Oesterle director ONE BAXTER PARKWAY, DEERFIELD IL 60015
Cynthia L Feldmann director 17 WINTHROP ROAD, WAYLAND MA 01778
Seth Loring Harrison director 230 PARK AVENUE, SUITE 2800, NEW YORK NY 10169
Timothy J Barberich director 40 ELM ST, CONCORD MA 01752
Douglas Evan Godshall director, officer: President & Chief Exec Officer SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Robert Bain Thomas director SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Denis Newell Wade director SUITE 4 LEVEL 46, 2 PARK STREET, SIDNEY C3 2000
Adage Capital Partners Gp, L.l.c. 10 percent owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Adage Capital Partners, L.p. 10 percent owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Adage Capital Advisors, L.l.c. 10 percent owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Robert Atchinson 10 percent owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Phillip Gross 10 percent owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
David Mcintyre officer: CFO & COO SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Muneer A Satter 10 percent owner C/O SATTER INVESTMENT MANAGEMENT, LLC, 676 NORTH MICHIGAN AVENUE, SUITE 4000, CHICAGO IL 60611

Heartware International (Heartware International) Headlines

From GuruFocus

Baron Funds Comments on HeartWare International

By Holly LaFon 05-05-2014

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,415 Shares

By GuruFocus Research GuruFocus Editor 11-25-2009

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 1,580 Shares

By GuruFocus Research GuruFocus Editor 12-04-2009

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,300 Shares

By GuruFocus Research GuruFocus Editor 02-27-2010

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 2,521 Shares

By GuruFocus Research GuruFocus Editor 12-08-2009

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 2,857 Shares

By GuruFocus Research GuruFocus Editor 02-24-2011

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,400 Shares

By GuruFocus Research GuruFocus Editor 12-01-2009

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 4,967 Shares

By GuruFocus Research GuruFocus Editor 01-30-2010

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 21,834 Shares

By GuruFocus Research GuruFocus Editor 04-30-2010

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 5,271 Shares

By GuruFocus Research GuruFocus Editor 03-09-2010